| Stem Cell Enriched
Cord Blood Repository |
|
Reliance Life Sciences has established
South Asia's first, most advanced and
completely automated stem cell enriched
umbilical cord blood repository. The repository
holds over 3500 units. This is the first
cord blood repository in the world to
be accorded a licence by an official regulatory
authority, Food and Drug Administration
(FDA), Government of India.
|
The repository runs two programs
for collection of cord blood - Relicord-S
and Relicord-A
- under its cord blood repository
program. Relicord-S
is a sibling donor program and Relicord-A
is meant for patients requiring
transplants with grafts from the
repository.
Cord blood is collected from donors
and is tested thoroughly for HIV,
HBV, HCV and CMV. The blood is also
typed for Human Leukocyte Antigens
(HLA) Class 1 and 2 antigens using
the most contemporary molecular
methods and then processed for enriching
stem cells. The repository cryo-preserves
stem cell enriched cord blood at
minus 196 deg Celsius in a computer
controlled robotics-based, bio-archive
system.
|
|
Stem cell enriched cord blood is used
as a therapy for the treatment of ß
thalassemia, leukaemia and sickle cell
anaemia and is an adjunct therapy for
aggressive chemotherapy.
HLA
Query
